ReviewThe American journal of tropical medicine and hygiene2013
Human infection with Shewanella putrefaciens and S. algae: report of 16 cases in Martinique and review of the literature.
Review in The American journal of tropical medicine and hygiene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
65 citing papers in PubMed.
- Bridging clinical and environmental reservoirs: antimicrobial resistance in the emerging pathogenAntimicrobial agents and chemotherapy · 2026Article
- Shewanella putrefaciens: A Rare Cause of Refractory Peritonsillar Abscess in an Immunocompetent Adult.Cureus · 2026Article
- Case Report: A case study of geriatric acute cholecystitis complicated by coinfection withFrontiers in medicine · 2026Article
- Clinical and laboratory characteristics of patients infected withFrontiers in cellular and infection microbiology · 2026Article
- Multidrug-resistantIDCases · 2026Article
- Shewanella algae as a Rare Cause of Bullous Cellulitis and Sepsis: The First Reported Case in Lithuania.Cureus · 2025Article
- Blue Crab (Animals : an open access journal from MDPI · 2025Article
- Article
- Spectroscopic characterization of bacterial colonies through UV hyperspectral imaging techniques.Frontiers in chemistry · 2025Article
- Left knee septic monoarthritis in a pediatric patient due to shewanella putrefaciens: case report and literature review.Annals of clinical microbiology and antimicrobials · 2024Review
- A Rare Cause of Empyema and Bacteremia Due to Shewanella Species in Alcoholic Cirrhosis Patients: A Case Report and Comprehensive Review of Literature.The American journal of case reports · 2024Review
- Article
- Genome characterization ofFrontiers in microbiology · 2024Article
- Prevalence and molecular characteristics ofFrontiers in microbiology · 2024Article
- Case Report: A Case of Sepsis due to Shewanella algae Infection in the Colombian Caribbean.The American journal of tropical medicine and hygiene · 2023Article
- The Outer Membrane Cytochrome OmcA Is Essential for Infection of Shewanella oneidensis by a Zebrafish-Associated Bacteriophage.Journal of bacteriology · 2023Article
- Shewanella putrefaciens: A Critically Emerging Pathogen of Ventilator-Associated Pneumonia.Cureus · 2023Article
- Case Report:F1000Research · 2023Article
- Review
- Phylogenomic diversity ofMicrobial genomics · 2022Article
5 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shewanella spp. are saprophytic bacteria that are part of the marine microflora in warm climates and are rarely pathogenic. However, Shewanella spp. infections are being increasingly reported, and there has been no comprehensive review of the literature describing these infections. This article reports 16 cases of Shewanella spp. infections in Martinique since 1997 and reviews another 239 cases reported in the literature since 1973. Patients experienced soft tissue infections, ear infection, or abdominal and biliary tract infections. A skin or mucosal portal of entry was found for 53% of the patients and exposure to the marine environment was reported for 44%; 79% of patients had an underlying condition. Bacteriema were frequent (28%). Most (87%) patients recovered, although ear infections can become chronic. Death occurred in 13% of the patients. Most Shewanella spp. isolates are susceptible to cefotaxime (95%), piperacillin and tazobactam (98%), gentamicin (99%), and ciprofloxacin (94%).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.